home / stock / ktta / ktta quote
Last: | $7.09 |
---|---|
Change Percent: | -5.03% |
Open: | $7.0999 |
Close: | $7.09 |
High: | $7.0999 |
Low: | $7.09 |
Volume: | 731 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.09 | $7.0999 | $7.09 | $7.0999 | $7.09 | 731 | 04-23-2024 |
$6.76 | $7.1 | $6.76 | $7.1 | $6.76 | 2,254 | 04-22-2024 |
$7.11 | $7.11 | $7.11 | $7.11 | $7.11 | 541 | 04-19-2024 |
$7.15 | $7.15 | $7.15 | $7.15 | $7.15 | 702 | 04-18-2024 |
$7.15 | $7.15 | $7.15 | $7.15 | $7.15 | 349 | 04-17-2024 |
$7.25 | $7.2926 | $7.25 | $7.2926 | $7.25 | 678 | 04-16-2024 |
$7.15 | $7.35 | $7.15 | $7.35 | $7.15 | 1,569 | 04-15-2024 |
$7.46 | $7.775 | $7.46 | $7.775 | $7.46 | 1,782 | 04-12-2024 |
$7.65 | $8.04 | $7.65 | $8.11 | $7.65 | 3,561 | 04-11-2024 |
$8.2 | $8 | $8.2 | $8.25 | $8 | 932 | 04-10-2024 |
$8.2458 | $8 | $8.2458 | $8.2458 | $8 | 1,582 | 04-09-2024 |
$8.45 | $8.8 | $8.45 | $9.25 | $8.45 | 3,061 | 04-08-2024 |
$8.5 | $7.85 | $8.5 | $8.5 | $7.85 | 2,763 | 04-05-2024 |
$8.75 | $7.8 | $8.75 | $8.75 | $7.4 | 14,346 | 04-04-2024 |
$7.99 | $7.15 | $7.99 | $8.1 | $7.15 | 8,774 | 04-03-2024 |
$7.2294 | $7.25 | $7.2294 | $7.35 | $7.225 | 7,748 | 04-02-2024 |
$7.2503 | $0 | $7.2503 | $0 | $0 | 244 | 04-01-2024 |
$7.2503 | $7.25 | $7.2503 | $7.2503 | $7.25 | 1,731 | 03-29-2024 |
$7.2503 | $7.25 | $7.2503 | $7.2503 | $7.25 | 1,731 | 03-28-2024 |
$7.15 | $7.1 | $7.15 | $7.15 | $7 | 1,502 | 03-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and MIAMI, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor for the ...
2024-04-16 18:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...